Novartis



Ebit تغيير تاريخ
AbbVie USD 5.65B 407M 2025-03
Alcon AG USD 511M 13M 2025-03
Almirall EUR -5483000 55.57M 2024-12
Amgen USD 3.6B 434M 2025-03
AstraZeneca USD 4.8B 604M 2025-03
Autolus Therapeutics Ltd -65240000 3.57M 2025-03
Bayer EUR 2.91B 2.06B 2025-03
Biogen USD 582.8M 61.3M 2025-03
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Eli Lilly USD 3.7B 1.93B 2025-03
Fresenius EUR 654M 8M 2025-03
Fresenius Medical Care EUR 446M 43M 2025-03
Galapagos EUR -158708000 95.99M 2025-03
Genmab DKK 1.33B 827.73M 2025-03
Gilead Sciences USD 2.89B 221M 2025-03
GlaxoSmithKline GBP 2.53B 1.1B 2025-03
GRIFOLS EUR 226.41M 43.08M 2024-12
Hikma Pharmaceutical USD 317M 85M 2024-12
J&J USD 7.39B 2.04B 2025-03
Lonza CHF 727M 193M 2024-12
Merck EUR 1.01B 138M 2025-03
Merck USD 5.22B 339M 2024-12
Novartis USD 4.86B 286M 2024-12
Novartis USD 4.86B 286M 2024-12
Novo Nordisk 38.79B 4.97B 2025-03
Orion EUR 77.9M 14.8M 2025-03
Pfizer USD 5.93B 1.31B 2025-03
Philips EUR 354M 283M 2025-03
Recordati EUR 195.8M 61M 2025-03
Regeneron Pharmaceuticals USD 913.7M 661M 2025-03
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.9B 824M 2025-03
UCB EUR 502M 168M 2024-12



Novartis - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.